DISHMAN CARBOGEN AMCIS
|
DISHMAN CARBOGEN AMCIS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.21 | -9.79 | -1.90 | 1.15 | -10.53 |
| CEPS(Rs) | 18.94 | 10.04 | 16.00 | 20.77 | 9.11 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 371.91 | 358.90 | 370.51 | 353.89 | 363.45 |
| Tax Rate(%) | 83.22 | -25.51 | 45.41 | 523.76 | -153.93 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 16.22 | 10.09 | 13.77 | 15.21 | 14.34 |
| EBIT Margin(%) | 6.59 | -0.09 | 1.29 | 2.46 | -0.91 |
| Pre Tax Margin(%) | 0.71 | -4.67 | -2.26 | -0.20 | -3.40 |
| PAT Margin (%) | 0.12 | -5.87 | -1.24 | 0.84 | -8.64 |
| Cash Profit Margin (%) | 10.95 | 6.02 | 10.40 | 15.21 | 7.47 |
| Performance Ratios | |||||
| ROA(%) | 0.03 | -1.61 | -0.33 | 0.21 | -2.00 |
| ROE(%) | 0.06 | -2.68 | -0.52 | 0.32 | -2.89 |
| ROCE(%) | 2.31 | -0.03 | 0.43 | 0.76 | -0.26 |
| Asset Turnover(x) | 0.28 | 0.28 | 0.27 | 0.25 | 0.23 |
| Sales/Fixed Asset(x) | 0.26 | 0.26 | 0.27 | 0.26 | 0.24 |
| Working Capital/Sales(x) | 9.84 | -4.18 | 20.11 | 5.11 | 4.62 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 3.85 | 3.78 | 3.75 | 3.92 | 4.20 |
| Receivable days | 77.38 | 74.96 | 80.42 | 76.23 | 95.27 |
| Inventory Days | 120.02 | 117.68 | 109.59 | 98.96 | 104.66 |
| Payable days | 172.74 | 141.75 | 145.87 | 147.90 | 176.50 |
| Valuation Parameters | |||||
| PER(x) | 1,053.24 | - | - | 161.20 | - |
| PCE(x) | 11.49 | 23.47 | 7.79 | 8.92 | 11.97 |
| Price/Book(x) | 0.59 | 0.66 | 0.34 | 0.52 | 0.30 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.84 | 2.01 | 1.49 | 1.94 | 1.34 |
| EV/Core EBITDA(x) | 10.17 | 16.67 | 9.97 | 11.08 | 8.21 |
| EV/EBIT(x) | 27.91 | -2,290.51 | 115.45 | 78.99 | -147.37 |
| EV/CE(x) | 0.63 | 0.69 | 0.47 | 0.60 | 0.31 |
| M Cap / Sales | 1.26 | 1.41 | 0.81 | 1.36 | 0.89 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 3.66 | 8.41 | 12.72 | 11.96 | -6.44 |
| Core EBITDA Growth(%) | 55.90 | -12.57 | -3.95 | 19.82 | -42.29 |
| EBIT Growth(%) | 7,906.55 | -107.36 | -40.83 | 401.72 | -106.72 |
| PAT Growth(%) | 102.11 | -414.93 | -265.46 | 110.91 | -204.18 |
| EPS Growth(%) | 102.11 | -414.94 | -265.46 | 110.91 | -204.24 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.36 | 0.35 | 0.31 | 0.26 | 0.20 |
| Current Ratio(x) | 1.14 | 0.75 | 1.07 | 1.30 | 1.32 |
| Quick Ratio(x) | 0.68 | 0.41 | 0.62 | 0.84 | 0.92 |
| Interest Cover(x) | 1.12 | -0.02 | 0.36 | 0.93 | -0.37 |
| Total Debt/Mcap(x) | 0.61 | 0.53 | 0.93 | 0.49 | 0.68 |
Compare Financial Ratios of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹4,498.6 Cr | -2.5% | 7.5% | 60.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹398,218.0 Cr | -0.7% | 3% | -13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,158.0 Cr | 1.9% | 8.3% | 5.8% | Stock Analytics | |
| CIPLA | ₹126,710.0 Cr | 0.5% | 0.7% | -2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹119,586.0 Cr | -0.1% | NA | 1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,496.0 Cr | -2% | -5.4% | -7.5% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -2.5% |
7.5% |
60.3% |
| SENSEX | 1.6% |
2.1% |
2.6% |
You may also like the below Video Courses
